A Naturally High Hairline Is Not a Disease

Many women with naturally high foreheads — 7+ cm from brow to hairline — are told their face has a "long appearance" or that the forehead "dominates." It is a cosmetic concern, not a medical one. Three legitimate procedures can lower the visual hairline. Each suits a different patient profile.

Option 1 — Forehead Reduction Surgery (Hairline Advancement)

A surgical procedure that physically removes a strip of forehead skin and advances the existing hairline downward. Performed by a plastic surgeon, not a hair-restoration team. Results are permanent and dramatic — a 2–3 cm lowering in a single session. Drawbacks: a fine linear scar at the new hairline (usually invisible once hair grows over it), longer recovery, and the procedure is genuinely surgical with the associated risks.

Option 2 — Follicular Hairline Lowering

A hair transplant in which 800–2,000 single-hair grafts are placed forward of the existing hairline to create a new, lower line. The hair grows naturally and is indistinguishable from the rest of your hair. Recovery is faster than surgery, results take 9–12 months to fully emerge, and density is naturally calibrated to your existing hair.

Option 3 — Hairline SMP Framing

For women who do not want surgery and do not want a transplant, SMP can be used to create a "soft framing" forward of the existing hairline. The pigment dots simulate fine baby hairs at the new lower position. The result is more subtle than a transplant, requires no recovery, and is permanent.

Choosing Between Them

• Want maximum lowering in one session: forehead reduction surgery
• Want real growing hair, willing to wait 9–12 months: follicular lowering
• Want zero downtime, modest visual change: SMP framing
• Have any active scarring alopecia or FFA: none of the above until disease stable

The Pre-op Work-up

Before any of these options, women undergo bloodwork to rule out hormonal or autoimmune causes of high hairline (FFA in particular can mimic a high natural hairline early in disease progression). Skipping this step risks operating on active disease — which produces poor results.